The switch from sulfonylurea to preprandial short- acting insulin analog substitution has an immediate and comprehensive beta-cell protective effect in patients with type 2 diabetes mellitus (Q42497420)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The switch from sulfonylurea to preprandial short- acting insulin analog substitution has an immediate and comprehensive beta-cell protective effect in patients with type 2 diabetes mellitus |
scientific article |
Statements
1 reference
The switch from sulfonylurea to preprandial short- acting insulin analog substitution has an immediate and comprehensive beta-cell protective effect in patients with type 2 diabetes mellitus (English)
1 reference
Andreas Pfützner
1 reference
Babette Lorra
1 reference
Michel R Abdollahnia
1 reference
Peter H Kann
1 reference
Dominik Mathieu
1 reference
Christine Pehnert
1 reference
Christina Oligschleger
1 reference
Marcel Kaiser
1 reference
Thomas Forst
1 reference
1 June 2006
1 reference
1 reference
8
1 reference
3
1 reference
375-384
1 reference
Identifiers
1 reference
1 reference